Alpha-1 Antitrypsin Deficiency: Inherited Emphysema
Treatment
Medication Therapy
Specific therapy has been available for inherited emphysema since 1987: a class of medicine called augmentation therapy. This medicine replaces the alpha-1 antitrypsin protein in the blood with normal alpha-1 antitrypsin from healthy plasma donors, and it is given in a vein. The dose is adjusted based on body weight, and this treatment is often given once a week. There are three brands of augmentation therapy. They include:
- Prolastin®
- AralastTM
- ZemairaTM
Surgery
Lung transplants or lung reduction surgery may be an option for people severely affected by Alpha-1.
Behavior Modification
In addition to medicines, the management of inherited emphysema includes:
- Avoidance of infection
- Techniques to bring up mucus
- Oxygen therapy
- Pulmonary rehabilitation
- Exercise and a healthy lifestyle
-
Giving up smoking and avoiding secondhand smoke. This is particularly important to managing inherited emphysema. Smoking can accelerate or speed the development of the Alpha-1 related emphysema and shorten the lifespan.
BACK: Diagnosis
This information has been approved by Robert Sandhaus, MD, and Janis Berend RN, MSN, C-ANP (January 2007).